Biomarin pharmaceutical market cap

WebFind the latest BioMarin Pharmaceutical Inc. (BMRN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 18.394B: Beta (5Y ... Discover historical prices for BMRN stock on Yahoo Finance. View daily, weekly or … Find the latest BioMarin Pharmaceutical Inc. (BMRN) stock discussion in Yahoo … Interactive Chart for BioMarin Pharmaceutical Inc. (BMRN), analyze all … View the basic BMRN option chain and compare options of BioMarin … See BioMarin Pharmaceutical Inc. (BMRN) stock analyst estimates, including … See the company profile for BioMarin Pharmaceutical Inc. (BMRN) including … Find out the direct holders, institutional holders and mutual fund holders for … Find out all the key statistics for BioMarin Pharmaceutical Inc. (BMRN), including … See BioMarin Pharmaceutical Inc. (BMRN) Environment, Social and Governance … Get the detailed quarterly/annual income statement for BioMarin Pharmaceutical … WebApr 13, 2024 · BioMarin Pharmaceutical Stock Performance. Is the Rally Ready to Begin for BioMarin Pharmaceutical? NASDAQ:BMRN opened at $97.96 on Thursday. The …

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by …

WebBiomarin Pharmaceutical Inc (BMRN) Stock Price & News - Google Finance Home BMRN • NASDAQ Biomarin Pharmaceutical Inc Follow Share $96.60 After Hours: $96.60 (0.00%) 0.00 Closed: Apr 3,... WebApr 10, 2024 · Biomarin Pharmaceutical Inc.'s market capitalization is $18.49 B by 186.53 M shares outstanding. Is Biomarin Pharmaceutical stock a Buy, Sell or Hold? … dynalight game https://corpdatas.net

BioMarin Pharmaceutical (BMRN) - Market capitalization

WebMar 22, 2024 · BioMarin Pharmaceutical Inc. (BMRN) NASDAQ: BMRN · IEX Real-Time Price · USD. Add to Watchlist 90.08-2.00 (-2.17%) ... Profile; Chart; BMRN Market Cap. … WebAccording to BioMarin Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $2.09 B . In 2024 the company made a revenue of $1.84 B a decrease over the years 2024 revenue that were of $1.86 B .The revenue is the total amount of income that a company generates by the sale of goods or services. WebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock... dynalight.net

BioMarin Pharmaceutical (BMRN) - Market capitalization

Category:Kistler Tiffany Companies LLC Sells 740 Shares of BioMarin ...

Tags:Biomarin pharmaceutical market cap

Biomarin pharmaceutical market cap

BioMarin Pharmaceutical - BMRN Stock Forecast, Price …

WebMarket Cap: $17.4B: Shares Short: 7M: Financials See more. Revenue (12 Mos) $2B: Revenue Growth (YoY) 19.5%: ... BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials. ... 770 Lindaro Street, San Rafael, CA, United States, 94901: Sector: Healthcare: Industry: Biotechnology: Full-Time Employees ... WebFeb 27, 2024 · BioMarin, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $537.54 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate...

Biomarin pharmaceutical market cap

Did you know?

WebBioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Monday, February 27, at 4:30 p.m. ET. January 8, 2024. BioMarin Announces Stable and Durable Annualized … WebCurrent and historical revenue charts for BioMarin Pharmaceutical. As of April 2024 BioMarin Pharmaceutical's TTM revenue is of $2.09 B. companies: 7,323 total market …

WebGet the latest Biomarin Pharmaceutical Inc (BMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed … WebApr 13, 2024 · The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15.

WebApr 12, 2024 · The stock has a market capitalization of $18.25 billion, a PE ratio of 132.22 and a beta of 0.38. BioMarin Pharmaceutical ( NASDAQ:BMRN – Get Rating) last announced its quarterly earnings... WebJan 22, 2024 · Market Cap. $19B. Today's Change (-1.56%) -$1.55. Current Price ... That's why I like BioMarin Pharmaceutical (BMRN-1.56%), a biotech company founded in …

WebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of $70.73 and a twelve month high...

WebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research … dyna light headache rackWebView the latest BioMarin Pharmaceutical Inc. (BMRN) stock price, news, historical charts, analyst ratings and financial information from WSJ. crystal star thin after 40WebBioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and ... Market … dynalight字体Web2 days ago · Technical analysis trends BIOMARIN PHARMACEUTICAL INC. Technical analysis Income Statement Evolution More Financials Consensus Consensus EPS Revisions More Estimates Revisions Managers and Directors More about the company Sector and Competitors More Results dynalight cameraWebApr 13, 2024 · The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. The business's fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. dyna lightsWebApr 11, 2024 · The firm has a market capitalization of $18.29 billion, a P/E ratio of 132.50 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a fifty-two week low of $70.73 and a fifty-two week high... dynaline clevis pinsWebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.It has offices and facilities in the United States, South America, … crystal starting with c